TTrialPathMatch Me to Trials
← Back to trials
RecruitingCarcinoma, Hepatocellular

Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

Eligible age

18+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This is an observational, prospective cohort study that will recruit a diverse sample of 84 participants with newly diagnosed with unresectable, advanced hepatocellular carcinoma (HCC) at the UT Health Cancer Center in San Antonio. This study uses geriatric assessment tools with participants 65 years and older and collects adverse events and exploratory markers of aging for all participants.

Sponsor: The University of Texas Health Science Center at San Antonio

You may qualify if…

  • ✓ Histologically or radiographically (CT or MRI) confirmed newly diagnosed hepatocellular carcinoma.
  • ✓ Age 18 years and older.
  • ✓ Patients with advanced, unresectable HCC as determined by the treating physician.

You may not qualify if…

  • ✕ Patients with resectable HCC who are still candidates for locoregional therapy
  • ✕ Patients receiving prior systemic or locoregional therapy

Where it's recruiting

Texas

San Antonio

Source: ClinicalTrials.gov · NCT03894917 · last updated 2026-01-08

Characterizing Disease Biology, Treatment and Toxicity in Older Adults · TrialPath